XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues:        
Total revenues $ 2,498 $ 268 $ 2,654 $ 1,234
Operating expenses:        
Research and development 39,687 26,252 71,348 53,049
General and administrative 9,128 7,221 18,231 13,861
Total operating expenses 48,815 33,473 89,579 66,910
Operating loss (46,317) (33,205) (86,925) (65,676)
Investment and other income, net 10,475 2,703 18,275 5,813
Net loss $ (35,842) $ (30,502) $ (68,650) $ (59,863)
Basic net loss per common share (in dollars per share) $ (0.54) $ (0.65) $ (1.10) $ (1.27)
Diluted net loss per common share (in dollars per share) $ (0.54) $ (0.65) $ (1.10) $ (1.27)
Shares used in calculating basic net loss per share (in shares) 66,019 47,253 62,445 47,233
Shares used in calculating diluted net loss per share (in shares) 66,019 47,253 62,445 47,233
Comprehensive loss:        
Net loss $ (35,842) $ (30,502) $ (68,650) $ (59,863)
Other comprehensive income (loss):        
Unrealized (loss) gain on marketable securities (464) (51) (1,528) 812
Comprehensive loss (36,306) (30,553) (70,178) (59,051)
Product development and licensing agreements        
Revenues:        
Total revenues   16 2 16
Contracts and grants        
Revenues:        
Total revenues $ 2,498 $ 252 $ 2,652 $ 1,218